<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>14</volume><submitter>Zhang X</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Esophageal squamous cell carcinoma (ESCC) accounts for 80% of esophageal cancer (EC) worldwide. The molecular characteristics of locally advanced ESCC have been extensively studied.&lt;h4>Methods&lt;/h4>In this study, we investigate the genomic and transcriptomic characteristics and try to provide the basic T-cell receptors (TCRs) dynamics and its genomic and transcriptome association during the radiochemotherapy of ESCC using multi-omics analysis.&lt;h4>Results&lt;/h4>A total of 23 patients with pathologic diagnoses of locally advanced ESCC were enrolled. The median tumor mutational burden (TMB) of the 23 ESCC patients were 3.47 mutations/ Mb (mega-base). The TP53, RTK/RAS, and NOTCH pathways were concurrently prevalent in ESCC. Besides, some less prevalent pathways, including WN</pubmed_abstract><journal>Frontiers in oncology</journal><pagination>1495200</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11743576</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.</pubmed_title><pmcid>PMC11743576</pmcid><pubmed_authors>Lian J</pubmed_authors><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li Z</pubmed_authors><pubmed_authors>Liang H</pubmed_authors><pubmed_authors>Jia S</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Chen F</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Xue H</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.</name><description>&lt;h4>Introduction&lt;/h4>Esophageal squamous cell carcinoma (ESCC) accounts for 80% of esophageal cancer (EC) worldwide. The molecular characteristics of locally advanced ESCC have been extensively studied.&lt;h4>Methods&lt;/h4>In this study, we investigate the genomic and transcriptomic characteristics and try to provide the basic T-cell receptors (TCRs) dynamics and its genomic and transcriptome association during the radiochemotherapy of ESCC using multi-omics analysis.&lt;h4>Results&lt;/h4>A total of 23 patients with pathologic diagnoses of locally advanced ESCC were enrolled. The median tumor mutational burden (TMB) of the 23 ESCC patients were 3.47 mutations/ Mb (mega-base). The TP53, RTK/RAS, and NOTCH pathways were concurrently prevalent in ESCC. Besides, some less prevalent pathways, including WN</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024</publication><modification>2025-04-22T05:15:40.143Z</modification><creation>2025-04-05T21:15:59.319Z</creation></dates><accession>S-EPMC11743576</accession><cross_references><pubmed>39834937</pubmed><doi>10.3389/fonc.2024.1495200</doi></cross_references></HashMap>